Teva, Purdue Put OxyContin Litigation Behind Them

Law360, New York (October 16, 2006, 12:00 AM EDT) -- A federal judge has signed off on the settlement agreement over a generic version of painkiller OxyContin between generic drug maker Teva Pharmaceuticals Industries Ltd. and Purdue Pharma LP, bringing pending litigation to an end.

Israel-based Teva was given a full release from the litigation and Stamford, Conn.-based pharmaceutical Purdue will not seek damages for past infringement, the companies said.

Under the terms of the settlement agreement, Teva will cease selling oxycodone products at an unspecified future date. Teva said that it anticipates sales of its...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.